Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

766 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Digital Pathology During the COVID-19 Outbreak in Italy: Survey Study.
Giaretto S, Renne SL, Rahal D, Bossi P, Colombo P, Spaggiari P, Manara S, Sollai M, Fiamengo B, Brambilla T, Fernandes B, Rao S, Elamin A, Valeri M, De Carlo C, Belsito V, Lancellotti C, Cieri M, Cagini A, Terracciano L, Roncalli M, Di Tommaso L. Giaretto S, et al. Among authors: fernandes b. J Med Internet Res. 2021 Feb 22;23(2):e24266. doi: 10.2196/24266. J Med Internet Res. 2021. PMID: 33503002 Free PMC article.
Hypofractionated volumetric modulated arc therapy in ductal carcinoma in situ: toxicity and cosmetic outcome from a prospective series.
De Rose F, Fogliata A, Franceschini D, Iftode C, Torrisi R, Masci G, Sagona A, Tinterri C, Testori A, Gatzemeier W, Fernandes B, Rahal D, Cozzi L, Santoro A, Scorsetti M. De Rose F, et al. Among authors: fernandes b. Br J Radiol. 2018 May;91(1085):20170634. doi: 10.1259/bjr.20170634. Epub 2018 Mar 20. Br J Radiol. 2018. PMID: 29322827 Free PMC article. Clinical Trial.
Single-cell profiling defines the prognostic benefit of CD39high tissue resident memory CD8+ T cells in luminal-like breast cancer.
Losurdo A, Scirgolea C, Alvisi G, Brummelman J, Errico V, Di Tommaso L, Pilipow K, Colombo FS, Fernandes B, Peano C, Testori A, Tinterri C, Roncalli M, Santoro A, Mazza EMC, Lugli E. Losurdo A, et al. Among authors: fernandes b. Commun Biol. 2021 Sep 22;4(1):1117. doi: 10.1038/s42003-021-02595-z. Commun Biol. 2021. PMID: 34552178 Free PMC article.
Author Correction: Single-cell profiling defines the prognostic benefit of CD39high tissue resident memory CD8+ T cells in luminal-like breast cancer.
Losurdo A, Scirgolea C, Alvisi G, Brummelman J, Errico V, Di Tommaso L, Pilipow K, Colombo FS, Fernandes B, Peano C, Testori A, Tinterri C, Roncalli M, Santoro A, Mazza EMC, Lugli E. Losurdo A, et al. Among authors: fernandes b. Commun Biol. 2021 Oct 27;4(1):1252. doi: 10.1038/s42003-021-02789-5. Commun Biol. 2021. PMID: 34707238 Free PMC article. No abstract available.
Primary brain necrotizing granulomas caused by Curvularia spicifera.
Bono BC, Olei S, Rossini Z, Fernandes B, Valeri M, Pessina F. Bono BC, et al. Among authors: fernandes b. Infect Dis Now. 2022 Sep;52(6):381-383. doi: 10.1016/j.idnow.2022.06.008. Epub 2022 Jul 5. Infect Dis Now. 2022. PMID: 35803530 No abstract available.
Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patients.
Gentile D, Sagona A, De Carlo C, Fernandes B, Barbieri E, Di Maria Grimaldi S, Jacobs F, Vatteroni G, Scardina L, Biondi E, Vinci V, Trimboli RM, Bernardi D, Tinterri C. Gentile D, et al. Among authors: fernandes b. Breast. 2023 Jun;69:323-329. doi: 10.1016/j.breast.2023.03.016. Epub 2023 Mar 28. Breast. 2023. PMID: 37001289 Free PMC article.
The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant Chemotherapy.
Tinterri C, Fernandes B, Zambelli A, Sagona A, Barbieri E, Di Maria Grimaldi S, Darwish SS, Jacobs F, De Carlo C, Iuzzolino M, Gentile D. Tinterri C, et al. Among authors: fernandes b. Cancers (Basel). 2024 Jan 16;16(2):376. doi: 10.3390/cancers16020376. Cancers (Basel). 2024. PMID: 38254865 Free PMC article.
Potential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: a single institution experience.
Torrisi R, Garcia-Etienne CA, Losurdo A, Morenghi E, Di Tommaso L, Gatzemeier W, Sagona A, Fernandes B, Rossetti C, Eboli M, Rubino A, Barbieri E, Andreoli C, Orefice S, Gandini C, Rota S, Zuradelli M, Masci G, Santoro A, Tinterri C. Torrisi R, et al. Among authors: fernandes b. Breast. 2013 Aug;22(4):419-24. doi: 10.1016/j.breast.2013.03.013. Epub 2013 May 3. Breast. 2013. PMID: 23643803
766 results